Insider Transactions in Q4 2024 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 30
2024
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
177,704
-19.34%
|
$1,954,744
$11.54 P/Share
|
Dec 30
2024
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+21.39%
|
$750,000
$3.85 P/Share
|
Dec 28
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,896
-0.69%
|
$20,856
$11.8 P/Share
|
Dec 27
2024
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
176,900
-20.92%
|
$1,945,900
$11.82 P/Share
|
Dec 27
2024
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+22.82%
|
$750,000
$3.85 P/Share
|
Dec 26
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
689,495
-3.53%
|
$8,273,940
$12.01 P/Share
|
Dec 26
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
689,495
+3.41%
|
$2,068,485
$3.85 P/Share
|
Dec 24
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
185,946
-0.98%
|
$2,231,352
$12.0 P/Share
|
Dec 24
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
185,946
+0.97%
|
$557,838
$3.85 P/Share
|
Dec 23
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
10,796
-0.06%
|
$129,552
$12.0 P/Share
|
Dec 23
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,796
+0.06%
|
$32,388
$3.85 P/Share
|
Dec 20
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.06%
|
$120,395
$11.57 P/Share
|
Dec 20
2024
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-14.38%
|
$1,100,000
$11.49 P/Share
|
Dec 20
2024
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+12.57%
|
$300,000
$3.85 P/Share
|
Dec 20
2024
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-1.8%
|
$120,395
$11.57 P/Share
|
Dec 20
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,087
-1.49%
|
$33,957
$11.57 P/Share
|
Dec 20
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,129
-0.77%
|
$23,419
$11.57 P/Share
|
Dec 18
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
412,584
-2.14%
|
$4,951,008
$12.05 P/Share
|
Dec 18
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
412,584
+2.1%
|
$1,237,752
$3.85 P/Share
|
Dec 03
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
SELL
Other acquisition or disposition
|
Direct |
3,651,985
-16.24%
|
$43,823,820
$12.21 P/Share
|
Nov 28
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,341
-0.84%
|
$28,092
$12.69 P/Share
|
Nov 20
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.06%
|
$120,395
$11.49 P/Share
|
Nov 20
2024
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-14.15%
|
$1,100,000
$11.32 P/Share
|
Nov 20
2024
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+12.4%
|
$300,000
$3.85 P/Share
|
Nov 20
2024
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-1.77%
|
$120,395
$11.49 P/Share
|
Nov 20
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
958
-0.46%
|
$10,538
$11.49 P/Share
|
Oct 28
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,341
-0.83%
|
$25,751
$11.84 P/Share
|
Oct 21
2024
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
2,303
+2.3%
|
-
|
Oct 21
2024
|
Epperly Melissa B, |
BUY
Grant, award, or other acquisition
|
Direct |
1,613
+4.07%
|
-
|
Oct 21
2024
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
1,231
+1.3%
|
-
|
Oct 21
2024
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-13.94%
|
$1,100,000
$11.65 P/Share
|
Oct 21
2024
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+12.23%
|
$300,000
$3.85 P/Share
|
Oct 20
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.06%
|
$120,395
$11.92 P/Share
|
Oct 20
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
956
-0.46%
|
$10,516
$11.92 P/Share
|
Oct 20
2024
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-1.74%
|
$120,395
$11.92 P/Share
|